These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 688755)

  • 1. Pharmacokinetic and pharmacodynamic studies of procainamide given intermittently intravenously in patients with severe ventricular arrhytmias.
    Wierzchowiecki M; Jasiński K; Trojanowicz R; Ochotny R; Tomaszkiewicz T
    Cor Vasa; 1978; 20(3):176-83. PubMed ID: 688755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Verification of therapeutic levels of procainamide and N-acetyl- procainamide in ventricular arrhythmia].
    Sinkiewicz W; Marzec A; Jankowski A; Hoffmann A; Makuch K; Romański B
    Pol Tyg Lek; 1990 Jun 4-11; 45(23-24):458-60. PubMed ID: 1703654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A new anti-arrhythmia drug. II. Comparative studies of the effects of a new acyl derivative of procainamide, procainamide and N-acetylprocainamide on blood pressure and the electrocardiogram in rabbits].
    Kusowska J
    Acta Pol Pharm; 1989; 46(1):90-7. PubMed ID: 2479226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conventional and sustained-release procainamide: update on pharmacology and clinical use.
    Anderson JL
    Clin Ther; 1985; 7(5):618-40. PubMed ID: 3902240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of intravenous amiodarone and procainamide in the treatment of atrial fibrillation of recent onset.
    Xanthos T; Prapa V; Papadimitriou D; Papadimitriou L
    Minerva Cardioangiol; 2007 Aug; 55(4):433-41. PubMed ID: 17653020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermittent intravenous procaine amide to treat ventricular arrhythmias. Correlation of plasma concentration with effect on arrhythmia, electrocardiogram, and blood pressure.
    Giardina EG; Heissenbuttel RH; Bigger JT
    Ann Intern Med; 1973 Feb; 78(2):183-93. PubMed ID: 4683748
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiarrhythmic prophylaxis with procainamide in acute myocardial infarction.
    Koch-Weser J; Klein SW; Foo-Canto LL; Kastor JA; DeSanctis RW
    N Engl J Med; 1969 Dec; 281(23):1253-60. PubMed ID: 4900236
    [No Abstract]   [Full Text] [Related]  

  • 8. [Intravenously disopyramide phosphate administration for treatment of arrhythmias].
    Aquaro G; Belli R; Pavia M; Rey L; Ravera A; Possavino G; Idone P
    G Ital Cardiol; 1982; 12(7):509-19. PubMed ID: 7169147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-acetylprocainamide's antiarrhythmic action in patients with ventricular tachycardia.
    Somberg J; Wynn J; Miura D; Torres V; Williams S; Keefe D
    Angiology; 1986 Dec; 37(12 Pt 2):972-81. PubMed ID: 2433972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Oral administration of procainamide for ventricular arrhythmia. Plasma concentrations during use of tablets(Pronestyl) and a slow-release preparation (Porcainamide Durettes)].
    Bliddal J
    Ugeskr Laeger; 1976 Sep; 138(40):2425-33. PubMed ID: 968996
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety and efficacy of procainamide infusions.
    Lima JJ; Goldfarb AL; Conti DR; Golden LH; Bascomb BL; Benedetti GM; Jusko WJ
    Am J Cardiol; 1979 Jan; 43(1):98-105. PubMed ID: 758776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral amiodarone in high-risk ventricular arrhythmias.
    Toruncha A; García-Barreto D; González-Gómez A; Llerena L; Sellén J; Ramos-Emperador C; Cabrera-Alonso C; Hernández-Cañero A
    Cor Vasa; 1982; 24(5):354-64. PubMed ID: 7172689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of procainamide and lidocaine on total electrical systole of ventricular premature depolarizations.
    Giardina EG; Bigger JT
    Am J Med; 1975 Sep; 59(3):405-10. PubMed ID: 1163548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of midazolam on pharmacokinetic parameters of procainamide in rabbits.
    Orszulak-Michalak D; Owczarek J; Wiktorowska-Owczarek AK
    Pol J Pharmacol; 2002; 54(2):151-5. PubMed ID: 12139112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative antiarrhythmic efficacy of intravenous N-acetylprocainamide and procainamide.
    Sonnhag C; Karlsson E
    Eur J Clin Pharmacol; 1979 Jun; 15(5):311-7. PubMed ID: 378673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of sotalol in twenty patients with cardiac arrhythmias.
    Latour Y; Dumont G; Brosseau A; LeLorier J
    Int J Clin Pharmacol Biopharm; 1977 Jun; 15(6):275-8. PubMed ID: 881280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-ranging trial of N-acetylprocainamide in patients with premature ventricular contractions.
    Atkinson AJ; Lee WK; Quinn ML; Kushner W; Nevin MJ; Strong JM
    Clin Pharmacol Ther; 1977 May; 21(5):575-87. PubMed ID: 322922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical pharmacology and antiarrhythmic efficacy of acetylprocainamide in patients with arrhythmias.
    Kluger J; Drayer D; Reidenberg M; Ellis G; Lloyd V; Tyberg T; Hayes J
    Am J Cardiol; 1980 Jun; 45(6):1250-7. PubMed ID: 6155064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective plasma concentration of N-acetylprocainamide in rats.
    Yacobi A; Krasula RW; Lai CM; Kamath BL
    Res Commun Chem Pathol Pharmacol; 1979 Apr; 24(1):197-200. PubMed ID: 432435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic efficacy of N-acetylprocainamide in patients with premature ventricular contractions.
    Lee WK; Strong JM; Kehoe RF; Dutcher JS; Atkinson AJ
    Clin Pharmacol Ther; 1976 May; 19(5 Pt 1):508-14. PubMed ID: 776488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.